07Dec
2018
2018
Stardog Adds Dan Yates to its Board of Directors
You will be redirected to: https://www.prweb.com/releases/stardog_adds_dan_yates_to_its_board_of_directors/prweb15972195.htm Read More
08Nov
2018
2018
miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
You will be redirected to: http://investors.miragen.com/Cache/1500114890.PDF?O=PDF&T=&Y=&D=&FID=1500114890&iid=4890649 Read More
29Oct
2018
2018
Science Meets Gratitude – Array BioPharma
Sorry, but you do not have permission to view this content.
08Sep
2018
2018
SyncHR and Hitachi Consulting Join Forces to Expand Reach of Cloud Human Capital Management Technology
You will be redirected to: https://globenewswire.com/news-release/2018/09/05/1565735/0/en/SyncHR-and-Hitachi-Consulting-Join-Forces-to-Expand-Reach-of-Cloud-Human-Capital-Management-Technology.html Read More
10Aug
2018
2018
Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors
You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-names-carrie-s-cox-chairman-its-board-directors Read More
07Aug
2018
2018
miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=394547646 Read More
27Jun
2018
2018
Array BioPharma Announces FDA Approval OF Braftovi™ (Encorafenib) in Combination with Mektovi® (Binimetinib)
You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-announces-fda-approval-braftovitm-encorafenib Read More
21Jun
2018
2018
Michael Sachse Named CEO of Stardog
You will be redirected to: https://www.prweb.com/releases/2018/06/prweb15573382.htm Read More
04Jun
2018
2018
Miragen Therapeutics to Present First Cobomarsen Phase 1 Clinical Trial Data From Patients With Adult T-Cell Leukemia/lymphoma and New Interim Data From Patients With Mycosis Fungoides at the 2018 American Society of Clinical Oncology Annual Meeting
You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=393751965 Read More
04Jun
2018
2018
Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma
You will be redirected to: http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-announces-additional-median-overall-survival Read More